Federation des caisses Desjardins du Quebec
Position in CGC — Canopy Growth Corp
CIK 2022297
LEVIS, A8
Position in CGC
as of Mar 31, 2026
· filed May 14, 2026
Position Value
$755,390
+$737,761 QoQ
Shares Held
795,987
+5047.0% QoQ
Ownership
0.189%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Dec 2023
10 quarters on record
Voting authority
Sole 100.ToString("F0")%
Shared 0.ToString("F0")%
None 0.ToString("F0")%
Common Shares in CGC Over Time
Shares Held
Position Value (USD)
Derivatives in CGC
reported options exposure · as of Jun 30, 2024CallValue
$154
CallShares
24
PutValue
$0
PutShares
0
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Mar 31, 2026Federation des caisses Desjardins du Quebec holds $37,941,198 across 32 Drug Manufacturers - Specialty & Generic names. CGC ranks #9 (2.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ZTS |
Zoetis Inc.
|
105,890 | $12,517,254 | |
| 2 | TEVA |
Teva Pharmaceutical Industries Ltd
|
285,623 | $8,602,962 | |
| 3 | UTHR |
UNITED THERAPEUTICS Corp
|
11,255 | $6,673,988 | |
| 4 | ALKS |
Alkermes plc.
|
66,144 | $2,338,851 | |
| 5 | ANIP |
Ani Pharmaceuticals Inc
|
26,930 | $2,070,915 | |
| 6 | VTRS |
Viatris Inc
|
94,833 | $1,281,191 | |
| 7 | ELAN |
Elanco Animal Health Inc
|
51,137 | $1,223,707 | |
| 8 | NBIX |
Neurocrine Biosciences Inc
|
8,564 | $1,128,218 |
All Filings in CGC
Export CSV
11 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $755,390 | 795,987 | Shares | Defined | 2026-05-14 | |
| 2025-12-31 | $17,629 | 15,465 | Shares | Defined | 2026-02-12 | |
| 2025-09-30 | $27,485 | 18,826 | Shares | Defined | 2025-11-14 | |
| 2025-06-30 | $16,918 | 13,868 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $12,587 | 13,832 | Shares | Defined | 2025-05-15 | |
| 2024-12-31 | $38,771 | 14,150 | Shares | Defined | 2025-02-14 | |
| 2024-09-30 | $88,234 | 18,306 | Shares | Defined | 2024-11-13 | |
| 2024-06-30 | $123,620 | 19,166 | Shares | Defined | 2024-08-14 | |
| 2024-06-30 | $154 | 24 | Call | Defined | 2024-08-14 | |
| 2024-03-31 | $88,966 | 10,309 | Shares | Defined | 2024-05-15 | |
| 2023-12-31 | $51,140 | 10,008 | Shares | Defined | 2024-08-15 | |
| No filing history on record for this holder in this stock. | ||||||